AFCEA28d
Air Force’s PEO C3I&N Looks to the Future
At the center of command and control for the Air Force, Hanscom Air Force Base and, in particular, the program executive officer (PEO) for Command, Control, Communications, Intelligence and Networks ...
The National Law Review22d
C3i Center, a Canadian company, receives approval from the EMA to manufacture cell therapy products for the European market
C3i, therefore, obtains a certificate of GMP (Good Manufacturing Practice) compliance, enabling it to make innovative medicines available to European patients. Last year, C3i became the first ...
Canadian Manufacturing22d
C3i to manufacture cell therapy products for European market
C3i also obtains a certificate of GMP compliance. MONTRÉAL — C3i Center obtains regulatory approval from the EMA (European Medicine Agency) to produce cell therapy treatments for the European ...
GEN22d
C3i Center Receives EMA Approval to Manufacture Cell Therapy Products for Europe
The Montreal-based C3i Center obtained regulatory approval from the European Medicine Agency (EMA) to produce cell therapy therapies for the European market. The company obtained a certificate of ...
Business Insider22d
C3i Center, a Canadian company, receives approval from the EMA to manufacture cell therapy products for the European market
MONTRÉAL, Feb. 19, 2025 (GLOBE NEWSWIRE) -- C3i Center (C3i) announces that it has obtained regulatory approval from the EMA (European Medicine Agency) to produce cell therapy treatments for the ...
Financial Post22d
C3i Center, a Canadian company, receives approval from the EMA to manufacture cell therapy products for the European market
MONTRÉAL, Feb. 19, 2025 (GLOBE NEWSWIRE) — C3i Center (C3i) announces that it has obtained regulatory approval from the EMA (European Medicine Agency) to produce cell therapy treatments for the ...
Finanznachrichten21d
Centre C3i Inc.: C3i Center, a Canadian company, receives approval from the EMA to manufacture cell therapy products for the European market
C3i, therefore, obtains a certificate of GMP (Good Manufacturing Practice) compliance, enabling it to make innovative medicines available to European patients. Last year, C3i became the first ...